Info
Exciva GmbH is a Heidelberg-based biopharmaceutical company founded in 2016, applying a transformational approach for clinical care of Alzheimer’s disease that fully integrates molecular, behavioral and chemistry technologies.
The product Deraphan© is the combination of two clinically validated products, acting in a safe manner on well documented pharmacological pathways in the field of neuropsychiatry. Deraphan© shows the unique potential to address both the neurological and psychological aspects of behavioral symptoms in Alzheimer and other dementia.
